The customer reported that while the iabp was in use on a patient, the iabp generated a ¿blood back¿ alarm and stopped pumping.
The iab treatment was suspended and no replacement unit was ordered.
The patient was considered terminal by the physician, so no replacement unit was placed on the patient or treatment attempted to be continued.
The patient coded 1 hour after treatment was suspended and coded again and died 5 hours after treatment was suspended.
It¿s unknown if the patient death is attributed to the reported event.
|